← Back to Search

Behavioral Intervention

Active Intervention Group for COVID-19 (ENGAGE Trial)

N/A
Waitlist Available
Led By Peter T Katzmarzyk, PhD
Research Sponsored by Pennington Biomedical Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and three weeks
Awards & highlights

ENGAGE Trial Summary

This trial will train church health ministers to teach their congregations about the safety and efficacy of COVID-19 vaccines and booster shots in order to decrease vaccine hesitancy and improve testing knowledge in underserved Black communities.

Eligible Conditions
  • COVID-19
  • Coronavirus

ENGAGE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and three weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and three weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in COVID-19 Vaccine/Booster Hesitancy from Baseline to 3 Weeks
Secondary outcome measures
Change in Vaccine/Booster Uptake from Baseline to 3 Weeks

ENGAGE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: COVID-19 Education GroupExperimental Treatment1 Intervention
Participants randomized to the intervention will be engaged over a three-week period in discussions by their health ministries; any identified concerns or barriers around the initial vaccination series and/or booster vaccinations will be addressed and the importance of continued COVID-19 testing will be emphasized. Evidence-based vaccine strategies that focus on positive framing will be employed
Group II: Delayed Control GroupActive Control1 Intervention
Participants in the delayed intervention control group will not receive any outreach during the three-week control period. Subsequent to completing the follow-up questionnaire, they will then be invited to join the intervention for the next three weeks. A follow-up questionnaire will be administered following their intervention period to be used in later analyses.

Find a Location

Who is running the clinical trial?

Pennington Biomedical Research CenterLead Sponsor
304 Previous Clinical Trials
181,436 Total Patients Enrolled
1 Trials studying COVID-19
120 Patients Enrolled for COVID-19
Peter T Katzmarzyk, PhDPrincipal InvestigatorPennington Biomedical Research Center
7 Previous Clinical Trials
2,146 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to participate in this clinical trial at present?

"Clinicaltrials.gov suggests that this treatment is not currently enrolling patients, as the listing was initially posted on January 15th 2023 and last edited November 7th 2022. Despite this trial's inactivity, there are still 1,036 other medical studies actively seeking participants right now."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Engaging Church Health Ministries to Decrease Coronavirus Disease-19 Vaccine Hesitancy in Underserved Populations
2023. "Engaging Church Health Ministries to Decrease Coronavirus Disease-19 Vaccine Hesitancy in Underserved Populations". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05541393.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top